PANAF-PREMIUM

Indications

• Enzyme replacement therapy
• Digestive disorders
• Metabolic disorders
• Cancer treatment
• Antibiotic treatment enhancement

Dosage

Children: Refer to specific guidelines for enzyme replacement therapies or digestive aids, as dosing varies by enzyme type and indication.

Adults: Refer to specific guidelines for enzyme replacement therapies or digestive aids, as dosing varies by enzyme type and indication.

Mechanism of action

Enzymes function by lowering the activation energy required for a chemical reaction, thus increasing the rate of the reaction. They bind to specific substrates at their active sites, forming enzyme-substrate complexes, which then undergo a transformation to produce the desired products while regenerating the enzyme for subsequent reactions.

Pharmacodynamics

The pharmacodynamic properties of enzymes are characterized by their catalytic efficiency, often described by parameters such as Km (Michaelis constant) and Vmax (maximum reaction velocity). Enzymes can be regulated through various mechanisms, including allosteric regulation, covalent modification, and feedback inhibition, allowing for precise control over metabolic pathways.

Pharmacokinetics

The pharmacokinetics of enzymes involve their absorption, distribution, metabolism, and excretion. Enzymes administered therapeutically may be subject to degradation by proteolytic enzymes in the gastrointestinal tract, influencing their bioavailability. Their distribution may vary based on the enzyme's size and solubility, and they can undergo modifications that affect their half-life and activity in the body.

Pregnancy

The safety of enzyme therapy during pregnancy varies depending on the specific enzyme. Consultation with a healthcare provider is recommended.

Breast-feeding

The transfer of enzymes into breast milk is variable. Caution is advised when administering enzyme therapy to breastfeeding mothers.

Storage

Store in a cool, dry place, away from direct sunlight and moisture. Specific storage conditions may vary based on the type of enzyme.

Indications

• Autism Spectrum Disorders
• Attention Deficit Hyperactivity Disorder (ADHD)
• Post-Traumatic Stress Disorder (PTSD)
• Anxiety Disorders
• Depression
• Cerebral Palsy
• Physical Rehabilitation

Dosage

Children: Refer to the specific therapeutic regimen determined by a healthcare professional, as equine therapy is individualized based on patient needs.

Adults: Refer to the specific therapeutic regimen determined by a healthcare professional, as equine therapy is individualized based on patient needs.

Mechanism of action

Equine therapy operates on several levels. The physical interaction with horses can enhance gross motor skills and encourage physical fitness. Psychologically, the bond formed between horse and human can foster emotional healing, reduce anxiety, and build confidence. The rhythmic motion of riding has been shown to have a calming effect on individuals, mimicking similar movements to those experienced in a therapeutic setting. Moreover, the social interaction involved in caring for and riding horses may improve communication skills and socialization.

Pharmacodynamics

Equine therapy itself does not involve pharmacological agents; however, it may influence the psychobiological pathways in the body. The interactions evoke hormonal responses that can alter levels of cortisol and adrenaline, enhancing relaxation and reducing stress. The therapeutic environment can also promote the release of endorphins, contributing to a sense of well-being and happiness.

Pharmacokinetics

As equine therapy does not involve drugs, pharmacokinetics is not applicable. However, the effects on the body can vary based on individual patient characteristics, the specific condition treated, and the duration and frequency of the therapy sessions. Factors such as age, physical condition, and psychological state can influence therapeutic outcomes.

Pregnancy

Equine products should be used with caution during pregnancy, as there is limited data on their safety. Consultation with a healthcare professional is recommended.

Breast-feeding

Safety during breastfeeding is not well established; therefore, caution is advised when using equine products in nursing mothers.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Primary immunodeficiency disorders
• Secondary immunodeficiency (e.g. due to HIV infection)
• Chronic inflammatory demyelinating polyneuropathy (CIDP)
• Immune thrombocytopenic purpura (ITP)
• Kawasaki disease
• Prevention of infections in at-risk populations (e.g. following bone marrow transplant)

Dosage

Children: Refer to the BNF for Children for age-appropriate dosing guidelines; specific doses depend on the clinical condition and patient age.

Adults: Refer to specific guidelines for dosing based on indication; typically varies based on clinical scenario and patient condition.

Mechanism of action

Immunoglobulin exerts its effects primarily through the neutralization of pathogens and toxins, opsonization, and the activation of the complement system. It modulates immune responses by influencing the activity of various immune cells, including B cells, T cells, and macrophages, thereby enhancing antibody production and regulating inflammation.

Pharmacodynamics

The pharmacodynamics of immunoglobulin involve its ability to bind to specific antigens, effectively neutralizing them and facilitating their clearance. It also plays a crucial role in modulating the immune response, providing immediate passive immunity and promoting the establishment of active immunity over time. The diverse mechanisms through which immunoglobulin operates include antibody-dependent cell-mediated cytotoxicity (ADCC) and inhibition of pro-inflammatory cytokines.

Pharmacokinetics

Immunoglobulin is typically administered intravenously or subcutaneously. After administration, it is distributed throughout the extracellular space. The half-life of immunoglobulin varies but is generally in the range of 21 to 30 days, depending on the specific formulation and the patient's individual characteristics. It is primarily eliminated through the reticuloendothelial system, with catabolism occurring in various tissues.

Contra-indications

• Hypersensitivity to immunoglobulin preparations
• Selective IgA deficiency with a history of hypersensitivity
• Severe hyperprolinemia

Adverse effects

• Headache
• Nausea
• Fever
• Chills
• Fatigue
• Rash
• Anaphylactic reactions
• Thromboembolic events

Interactions

• Live attenuated vaccines may be less effective if administered concurrently with immunoglobulin therapy
• Caution is advised when administering with other blood products

Precautions

• Monitor for signs of anaphylaxis during and after administration
• Use with caution in patients with renal impairment
• Hydrate adequately to prevent renal dysfunction
• Consider the risk of thrombosis in patients with a history of thromboembolic events

Pregnancy

Immunoglobulin can be used during pregnancy if indicated, as it is considered safe based on available data.

Breast-feeding

Immunoglobulin is excreted in breast milk, but is generally considered safe during breastfeeding.

Storage

Store at 2-8 degrees Celsius. Do not freeze. Protect from light. Use before expiry date.

Formulations

• Intravenous immunoglobulin (IVIG)
• Subcutaneous immunoglobulin (SCIG)
• Intramuscular immunoglobulin (IMIG)

Indications

• Vaccination against multiple infectious diseases
• Preventive immunization in at-risk populations
• Post-exposure prophylaxis for certain infections

Dosage

Children: Refer to specific product guidelines for paediatric dosing, as it varies by vaccine type.

Adults: Refer to specific product guidelines for adult dosing, as it varies by vaccine type.

Mechanism of action

Polyvalent vaccines stimulate the immune system to produce antibodies against multiple pathogen types simultaneously. By introducing a mixture of antigens, the vaccine activates both humoral and cell-mediated immunity, preparing the immune system to recognize and combat pathogens upon future exposure.

Pharmacodynamics

The pharmacodynamic effect of polyvalent vaccines involves the generation of a robust immune response. This includes the activation of B cells to produce specific antibodies, T helper cell activation to support B cell function, and the generation of memory cells for long-term immunity. The efficacy can vary based on the individual's immune status and the specific antigens included in the vaccine.

Pharmacokinetics

Polyvalent vaccines are typically administered intramuscularly or subcutaneously. After administration, the vaccine components are taken up by antigen-presenting cells, which then process the antigens and present them to T cells. The onset of immunity generally occurs within weeks as antibodies are produced and memory cells are formed. The duration of immunity varies depending on the specific antigens and the individual's response.

Pregnancy

Polyvalent vaccines may be administered during pregnancy, but the risk-benefit should be evaluated. Live vaccines are generally contraindicated.

Breast-feeding

Polyvalent vaccines can be administered during breastfeeding as they are not expected to pose a risk to the infant.

Storage

Store polyvalent vaccines according to the manufacturer's instructions, typically in a refrigerator at 2-8°C. Do not freeze.

Dosage

Children: Refer to specific product guidelines for dosing information.

Adults: Refer to specific product guidelines for dosing information.

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Abdominal pain
• Headache
• Dizziness
• Fatigue

Precautions

• Use with caution in patients with a history of gastrointestinal disorders.
• Monitor for signs of allergic reactions.

Pregnancy

Safety in pregnancy has not been established, use only if clearly needed.

Breast-feeding

Consult a healthcare provider before use while breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Snake bites
• Envenomation
• Antivenom therapy
• Supportive care for systemic effects

Dosage

Children: For snake bites in children, refer to specific antivenom guidelines and local protocols. Dosing is typically adjusted based on weight and severity of envenomation.

Adults: For snake bites, refer to specific antivenom guidelines and local protocols. Dosing varies based on the type of snake, severity of envenomation, and clinical presentation.

Mechanism of action

The mechanisms of action of snake venom components vary widely. Neurotoxins interfere with neurotransmission by blocking acetylcholine receptors at the neuromuscular junction, leading to paralysis. Hemotoxins can disrupt blood coagulation pathways and damage blood vessels, causing hemorrhage and tissue necrosis. Cytotoxins can cause direct damage to cells and tissues, leading to pain and inflammation.

Pharmacodynamics

The pharmacodynamics of snake venom is characterized by its ability to interact with specific biological targets in the body, leading to a range of toxic effects. For example, neurotoxins can cause rapid onset of muscle paralysis, while hemotoxins can lead to bleeding and organ dysfunction. The effects depend on the dose, route of exposure, and individual susceptibility. The toxicity of snake venom can vary greatly between different species and individual snakes.

Pharmacokinetics

The pharmacokinetics of snake venom is not well characterized due to its complex nature and variability. Generally, venom components are rapidly absorbed into the bloodstream following envenomation. Distribution occurs systemically, affecting various tissues and organs. Metabolism can involve enzymatic breakdown by host tissues, while excretion pathways are not well defined. Severity of symptoms and toxicity can depend on the specific components of the venom and the patient's health status.

Adverse effects

• Local tissue necrosis
• Allergic reactions
• Systemic reactions
• Hemolysis
• Coagulation disorders

Precautions

• Use with caution in individuals with a history of allergic reactions to snake venom
• Monitor for signs of severe allergic reactions
• Assess local tissue condition after envenomation

Pregnancy

Safety during pregnancy is not established; use only if the benefits outweigh risks.

Breast-feeding

Safety during breastfeeding is not established; consult healthcare providers.

Storage

Store in a cool, dry place away from direct sunlight. Specific storage conditions may vary based on formulation.

Mechanism of action

Venoms exert their effects through various mechanisms, including enzymatic activity that disrupts cellular integrity, inhibition of neurotransmitter release, and modulation of ion channels. For example, neurotoxic venoms may block acetylcholine receptors at neuromuscular junctions, leading to paralysis. Other venoms can activate or inhibit specific receptors or pathways, resulting in pain, inflammation, or coagulation disturbances.

Pharmacodynamics

The pharmacodynamics of venom components depend on their specific targets and effects. Many venoms are designed to incapacitate prey quickly, with rapid onset of action. Effects may include paralysis, hemorrhage, or disruption of normal physiological functions. The potency and duration of action vary widely among different venoms and their constituent molecules.

Pharmacokinetics

Pharmacokinetics of venom components can vary significantly based on their structure and the route of exposure. After envenomation, the compounds may be rapidly absorbed into the bloodstream, leading to systemic effects. Metabolism typically occurs in the liver, and excretion can happen through urine or feces. The onset of action can be immediate, while the duration depends on the specific venom type and individual response.

Pregnancy

There is limited information on the use of venom during pregnancy. Use only if the potential benefit justifies the potential risk to the fetus.

Breast-feeding

Caution is advised when using venom while breastfeeding due to the unknown effects on the infant.

Storage

Store in a cool, dry place, away from direct sunlight. Specific storage conditions may vary depending on the formulation.